Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	288.92	265.72	227.07	198.45	173.25	122.63
Revenue Growth (YoY)	18.75%	17.02%	14.42%	14.55%	41.28%	-1.37%
Cost of Revenue	153.82	133.18	115.1	96.55	84.05	64.23
Gross Profit	135.1	132.54	111.97	101.9	89.2	58.4
Selling, General & Admin	13.93	13.93	12.09	11.69	9.87	7.82
Other Operating Expenses	42.08	42.08	32.86	33.25	25.77	17.2
Operating Expenses	78.75	76.89	61.93	59.94	49.73	38.57
Operating Income	56.34	55.65	50.04	41.96	39.46	19.83
Interest Expense	-1.89	-1.22	-0.57	-0.42	-0.46	-0.54
Interest & Investment Income	0.19	0.3	0.15	0.07	0	0.01
Earnings From Equity Investments	-0.02	-0.02	-0.01	-0.06	-0.03	0.2
Currency Exchange Gain (Loss)	0.04	0.04	0.01	-0	-0	-
Other Non Operating Income (Expenses)	1.22	1.22	0.07	-0.4	-0.04	-0
EBT Excluding Unusual Items	55.89	55.96	49.68	41.15	38.93	19.51
Asset Writedown	0.03	0.03	-0.03	-0.47	-0.03	-
Other Unusual Items	-	-	-	-	-	0.68
Pretax Income	55.91	55.99	49.65	40.68	38.9	20.19
Income Tax Expense	15.94	14.86	12.92	10.53	10.97	6.05
Earnings From Continuing Operations	39.98	41.14	36.73	30.15	27.93	14.13
Minority Interest in Earnings	-0.93	-0.93	-0.76	-0.63	-0.54	-0.19
Net Income	39.05	40.21	35.97	29.52	27.39	13.94
Net Income to Common	39.05	40.21	35.97	29.52	27.39	13.94
Net Income Growth	1.65%	11.77%	21.86%	7.77%	96.46%	8.96%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change (YoY)	-0.15%	-1.85%	-	-	0.01%	-0.01%
EPS (Basic)	2.40	2.51	2.21	1.81	1.68	0.86
EPS (Diluted)	2.40	2.51	2.21	1.81	1.68	0.86
EPS Growth	1.81%	13.88%	21.86%	7.77%	96.43%	8.97%
Free Cash Flow	41.86	36	35.13	39.35	36.28	23.64
Free Cash Flow Per Share	2.57	2.25	2.15	2.41	2.23	1.45
Dividend Per Share	-	1.570	1.570	1.300	1.030	0.552
Dividend Growth	-	-	20.77%	26.21%	86.59%	-
Gross Margin	46.76%	49.88%	49.31%	51.35%	51.49%	47.62%
Operating Margin	19.50%	20.94%	22.04%	21.14%	22.78%	16.17%
Profit Margin	13.51%	15.13%	15.84%	14.88%	15.81%	11.37%
Free Cash Flow Margin	14.49%	13.55%	15.47%	19.83%	20.94%	19.28%
EBITDA	78.19	75.63	66.5	56.76	53.35	33.21
EBITDA Margin	27.06%	28.46%	29.29%	28.60%	30.80%	27.08%
D&A For EBITDA	21.84	19.98	16.46	14.8	13.89	13.38
EBIT	56.34	55.65	50.04	41.96	39.46	19.83
EBIT Margin	19.50%	20.94%	22.04%	21.14%	22.78%	16.17%
Effective Tax Rate	28.50%	26.53%	26.02%	25.89%	28.19%	29.99%
Advertising Expenses	-	12.14	10.31	9.86	8.42	5.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.